Dual Antiplatelet Therapy Proves Mettle in Minor Stroke
DALLAS — Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute minor stroke who presented within 4.5 hours of onset, and had no “clearly disabling deficit,” functional outcome was similar between the two methods, according to Thanh […]